Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative review

Detalhes bibliográficos
Autor(a) principal: Rodrigues , Júlia Medeiros dos Santos
Data de Publicação: 2022
Outros Autores: Oliveira, José João Felipe Costa de, Figueiredo, Thaise de Gomes, Cabral, Adriane Borges, Silva, Juliane Cabral
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/33187
Resumo: Anxiety disorders are the most prevalent group of psychiatric pathologies. Within the context of new therapies for anxiety, phytotherapy has stood out positively. Thus, this review aims to study the action of Silexan in anxiety disorders, based on the Hamilton Anxiety Scale (HAM-A), making a parallel with other anxiolytic drugs of well-defined use in psychiatry. This is an integrative review type research, which included clinical trials with human beings. The search was carried out through online access to the databases PUBMED, SciELO, LILACS, Scopus, Web of Science, and Science Direct. The strategy for selection of articles followed the steps: search of the selected databases, reading of the title and abstract of all articles and exclusion of those that did not address the review topic, critical reading of the articles in full, and exclusion of those that did not meet the inclusion criteria. Thus, a total of 5 articles were selected. In all clinical trials, the use of Silexan showed higher response and remission rates compared to other interventions. Thus, it can be concluded that Silexan has some effectiveness in controlling anxiety. However, this study has limitations in that the included studies varied in number of participants, patient health status, and comparison. In addition, it would be interesting to test the use of Silexan in higher doses, making a comparison with the use of anxiolytic drugs in therapeutic doses already consolidated.
id UNIFEI_3b83b0ab5aa078a81908d1612e222cd5
oai_identifier_str oai:ojs.pkp.sfu.ca:article/33187
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative reviewEficacia de Silexan en comparación con otros fármacos ansiolíticos en el control de la ansiedad: una revisión integradoraEficácia do uso do Silexan em comparação com outros fármacos ansiolíticos no controle da ansiedade: uma revisão integrativaLavandulaAnsiolíticosFitoterapia.LavandulaAnti-Anxiety agentPhytotherapy. LavandaAnsiolíticoFitoterapia.Anxiety disorders are the most prevalent group of psychiatric pathologies. Within the context of new therapies for anxiety, phytotherapy has stood out positively. Thus, this review aims to study the action of Silexan in anxiety disorders, based on the Hamilton Anxiety Scale (HAM-A), making a parallel with other anxiolytic drugs of well-defined use in psychiatry. This is an integrative review type research, which included clinical trials with human beings. The search was carried out through online access to the databases PUBMED, SciELO, LILACS, Scopus, Web of Science, and Science Direct. The strategy for selection of articles followed the steps: search of the selected databases, reading of the title and abstract of all articles and exclusion of those that did not address the review topic, critical reading of the articles in full, and exclusion of those that did not meet the inclusion criteria. Thus, a total of 5 articles were selected. In all clinical trials, the use of Silexan showed higher response and remission rates compared to other interventions. Thus, it can be concluded that Silexan has some effectiveness in controlling anxiety. However, this study has limitations in that the included studies varied in number of participants, patient health status, and comparison. In addition, it would be interesting to test the use of Silexan in higher doses, making a comparison with the use of anxiolytic drugs in therapeutic doses already consolidated.Los trastornos de ansiedad son el grupo de patologías psiquiátricas más frecuente. En el contexto de las nuevas terapias para la ansiedad, la fitoterapia ha destacado positivamente. Así, esta revisión pretende estudiar la acción de Silexan en los trastornos de ansiedad, basándose en una escala de ansiedade, haciendo un paralelismo con otros fármacos ansiolíticos de uso bien definido en psiquiatría. Se trata de una investigación del tipo revisión integradora, que incluyó ensayos clínicos con seres humanos. La investigación se realizó mediante el acceso en línea a las bases de datos PUBMED, SciELO, LILACS, Scopus, Web of Science y Science Direct. La estrategia de selección de los artículos siguió los siguientes pasos: búsqueda en las bases de datos seleccionadas, lectura del título y del resumen de todos los artículos y exclusión de los que no abordaban el tema de la revisión, lectura crítica de los artículos en su totalidad y exclusión de los que no cumplían los criterios de inclusión. En todos los ensayos clínicos, el uso de Silexan mostró mayores tasas de respuesta y remisión en comparación con otras intervenciones. Por lo tanto, es posible concluir que Silexan tiene cierta eficacia en el control de la ansiedad. Sin embargo, este estudio tiene limitaciones, ya que los estudios incluidos variaban en cuanto al número de participantes, el estado de salud de los pacientes y la comparación. Además, sería interesante probar el uso de Silexan en dosis más altas, haciendo una comparación con el uso de fármacos en dosis terapéuticas ya consolidadas.Os transtornos ansiosos são o grupo de patologias psiquiátricas mais prevalentes. Dentro do contexto de novas terapêuticas para ansiedade, a fitoterapia tem se destacado positivamente. Dessa forma, essa revisão se propõe a estudar a ação do Silexan nos transtornos ansiosos, a partir da Escala para Ansiedade Hamilton (HAM-A), fazendo um paralelo com outras drogas ansiolíticas de uso já bem delimitado na psiquiatria. Trata-se de uma pesquisa do tipo revisão integrativa, que incluiu ensaios clínicos com seres humanos. A pesquisa foi realizada através do acesso online às bases de dados PUBMED, SciELO, LILACS, Scopus, Web of Science e Science Direct. A estratégia para seleção dos artigos seguiu as etapas: busca nas bases de dados selecionadas, leitura do título e resumo de todos os artigos e exclusão daqueles que não abordavam o tema da revisão, leitura crítica dos artigos na íntegra e exclusão daqueles que não preenchiam os critérios de inclusão. Dessa maneira, foram selecionados um total de 05 artigos. Em todos os ensaios clínicos, o uso de Silexan demonstrou maiores taxas de resposta e remissão, em comparação com outras intervenções. Dessa forma, é possível concluir que o Silexan possui alguma efetividade no controle da ansiedade. No entanto, esse estudo apresenta limitações na medida em que os estudos incluídos eram variados em número de participantes, estado de saúde dos pacientes e comparação. Além disso, seria interessante testar o uso de Silexan em doses maiores, fazendo um comparativo com uso de medicações ansiolíticas nas doses terapêuticas já consolidadas.Research, Society and Development2022-08-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3318710.33448/rsd-v11i11.33187Research, Society and Development; Vol. 11 No. 11; e269111133187Research, Society and Development; Vol. 11 Núm. 11; e269111133187Research, Society and Development; v. 11 n. 11; e2691111331872525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/33187/28421Copyright (c) 2022 Júlia Medeiros dos Santos Rodrigues ; José João Felipe Costa de Oliveira; Adriane Borges Cabral; Thaise de Gomes Figueiredo; Juliane Cabral Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRodrigues , Júlia Medeiros dos Santos Oliveira, José João Felipe Costa de Figueiredo, Thaise de Gomes Cabral, Adriane Borges Silva, Juliane Cabral 2022-09-05T13:24:46Zoai:ojs.pkp.sfu.ca:article/33187Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:48:54.829390Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative review
Eficacia de Silexan en comparación con otros fármacos ansiolíticos en el control de la ansiedad: una revisión integradora
Eficácia do uso do Silexan em comparação com outros fármacos ansiolíticos no controle da ansiedade: uma revisão integrativa
title Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative review
spellingShingle Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative review
Rodrigues , Júlia Medeiros dos Santos
Lavandula
Ansiolíticos
Fitoterapia.
Lavandula
Anti-Anxiety agent
Phytotherapy.
Lavanda
Ansiolítico
Fitoterapia.
title_short Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative review
title_full Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative review
title_fullStr Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative review
title_full_unstemmed Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative review
title_sort Efficacy of Silexan compared with other anxiolytic drugs in the controlo of anxiety: na integrative review
author Rodrigues , Júlia Medeiros dos Santos
author_facet Rodrigues , Júlia Medeiros dos Santos
Oliveira, José João Felipe Costa de
Figueiredo, Thaise de Gomes
Cabral, Adriane Borges
Silva, Juliane Cabral
author_role author
author2 Oliveira, José João Felipe Costa de
Figueiredo, Thaise de Gomes
Cabral, Adriane Borges
Silva, Juliane Cabral
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Rodrigues , Júlia Medeiros dos Santos
Oliveira, José João Felipe Costa de
Figueiredo, Thaise de Gomes
Cabral, Adriane Borges
Silva, Juliane Cabral
dc.subject.por.fl_str_mv Lavandula
Ansiolíticos
Fitoterapia.
Lavandula
Anti-Anxiety agent
Phytotherapy.
Lavanda
Ansiolítico
Fitoterapia.
topic Lavandula
Ansiolíticos
Fitoterapia.
Lavandula
Anti-Anxiety agent
Phytotherapy.
Lavanda
Ansiolítico
Fitoterapia.
description Anxiety disorders are the most prevalent group of psychiatric pathologies. Within the context of new therapies for anxiety, phytotherapy has stood out positively. Thus, this review aims to study the action of Silexan in anxiety disorders, based on the Hamilton Anxiety Scale (HAM-A), making a parallel with other anxiolytic drugs of well-defined use in psychiatry. This is an integrative review type research, which included clinical trials with human beings. The search was carried out through online access to the databases PUBMED, SciELO, LILACS, Scopus, Web of Science, and Science Direct. The strategy for selection of articles followed the steps: search of the selected databases, reading of the title and abstract of all articles and exclusion of those that did not address the review topic, critical reading of the articles in full, and exclusion of those that did not meet the inclusion criteria. Thus, a total of 5 articles were selected. In all clinical trials, the use of Silexan showed higher response and remission rates compared to other interventions. Thus, it can be concluded that Silexan has some effectiveness in controlling anxiety. However, this study has limitations in that the included studies varied in number of participants, patient health status, and comparison. In addition, it would be interesting to test the use of Silexan in higher doses, making a comparison with the use of anxiolytic drugs in therapeutic doses already consolidated.
publishDate 2022
dc.date.none.fl_str_mv 2022-08-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/33187
10.33448/rsd-v11i11.33187
url https://rsdjournal.org/index.php/rsd/article/view/33187
identifier_str_mv 10.33448/rsd-v11i11.33187
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/33187/28421
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 11; e269111133187
Research, Society and Development; Vol. 11 Núm. 11; e269111133187
Research, Society and Development; v. 11 n. 11; e269111133187
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052770055880704

Registros relacionados